Method for labeling antibodies with a metal ion
    2.
    发明授权
    Method for labeling antibodies with a metal ion 失效
    用金属离子标记抗体的方法

    公开(公告)号:US5177192A

    公开(公告)日:1993-01-05

    申请号:US600326

    申请日:1990-10-19

    IPC分类号: A61K51/10

    摘要: Methods for rapidly labeling sulfhydryl-containing antibodies or fragments with technetium or rhenium radioisotopes are disclosed. The method generally involves combining an aqueous mixture of the radiometal in an oxidized form, a reducing agent and a water-soluble polyhydroxycarbonylic acid ligand to form a stable complex of the radiometal in its reduced state and contacting the mixture with the sulfhydryl-containing antibody or fragment to produce a radiometal-labeled antibody or fragment.

    摘要翻译: 公开了用锝或铼放射性同位素快速标记含巯基的抗体或片段的方法。 该方法通常涉及将氧化形式的放射性金属的水性混合物,还原剂和水溶性多羟基羰基酸配体组合以形成其还原状态的放射性金属的稳定配合物,并将该混合物与含巯基的抗体或 片段以产生放射性金属标记的抗体或片段。

    Technetium-99m labeled peptides for imaging
    3.
    发明授权
    Technetium-99m labeled peptides for imaging 失效
    锝-99m标记肽成像

    公开(公告)号:US06667389B1

    公开(公告)日:2003-12-23

    申请号:US08889212

    申请日:1997-07-08

    IPC分类号: A61K5108

    摘要: This invention relates to radiolabeled peptides and methods for producing such peptides. Specifically, the invention relates to peptides, methods and kits for making such peptides, and methods for using such peptides to image sites in a mammalian body labeled with technetium-99m (Tc-99m) via (Tc-99m) binding moieties. In particular, the peptide reagents of the invention are covalently linked to a polyvalent linker moiety, so that the polyvalent linker moiety is covalently linked to a multiplicity of the specific-binding peptides, and the Tc-99m binding moieties are covalently linked to a plurality of the specific-binding peptides, the polyvalent linker moiety, or to both the specific-binding peptides and the polyvalent linker moiety.

    摘要翻译: 本发明涉及放射性标记的肽及其生产方法。 具体地说,本发明涉及用于制备这些肽的肽,方法和试剂盒,以及使用这些肽在通过(Tc-99m)结合部分用锝-99m(Tc-99m)标记的哺乳动物体中成像位点的方法。 特别地,本发明的肽试剂与多价接头部分共价连接,使得多价接头部分与多种特异性结合肽共价连接,并且Tc-99m结合部分共价连接至多个 的特异性结合肽,多价连接体部分或特异性结合肽和多价连接体部分。

    Calcitonin receptor binding reagents
    4.
    发明授权
    Calcitonin receptor binding reagents 失效
    降钙素受体结合试剂

    公开(公告)号:US06479032B1

    公开(公告)日:2002-11-12

    申请号:US09553493

    申请日:2000-04-20

    IPC分类号: A61K5100

    CPC分类号: C07K14/585 A61K38/00

    摘要: This invention relates to calcitonin receptor binding reagents comprising compounds which are covalently linked to a radiometal chelator. The invention is embodied as calcitonin receptor binding peptide derivatives and analogues of calcitonin which may be radiolabeled with a suitable isotope and used as radiodiagnostic or radiotherapeutic agents. Methods and kits for making, radiolabeling and using such reagents diagnostically and therapeutically in a mammalian body are also provided.

    摘要翻译: 本发明涉及包含与放射性金属螯合剂共价连接的化合物的降钙素受体结合试剂。 本发明体现为降钙素受体结合肽衍生物和降钙素类似物,其可以用合适的同位素放射标记并用作放射诊断或放射治疗剂。 还提供了用于在哺乳动物身体中诊断和治疗地制备,放射性标记和使用这些试剂的方法和试剂盒。

    Radiolabeled glucans which bind to leukocytes, sites of infection,
inflammation, atherosclerosis, or cancer
    9.
    发明授权
    Radiolabeled glucans which bind to leukocytes, sites of infection, inflammation, atherosclerosis, or cancer 失效
    结合白细胞,感染部位,炎症,动脉粥样硬化或癌症的放射性标记的葡聚糖

    公开(公告)号:US5879660A

    公开(公告)日:1999-03-09

    申请号:US579449

    申请日:1995-12-27

    申请人: Richard T. Dean

    发明人: Richard T. Dean

    摘要: This invention relates to radiodiagnostic agents and reagents for preparing such agents, and also methods for producing radiolabeled radiodiagnostic agents. Specifically, the invention relates to technetium-99m (.sup.99m Tc) labeled agents, methods and kits for making the agents, and methods for using the agents to image pathological sites, including sites of infection, inflammation, cancer and atherosclerosis in a mammalian body. Specifically the agents and reagents are derivatives of oligosaccharides, more specifically .beta.-glucans.

    摘要翻译: 本发明涉及用于制备这种试剂的放射性诊断剂和试剂,以及用于制备放射性标记的放射诊断剂的方法。 具体地,本发明涉及用于制备该试剂的99-锝-99m(99mTc)标记的试剂,方法和试剂盒,以及用于使哺乳动物体内包含感染,炎症,癌症和动脉粥样硬化部位的病理部位成像的方法。 具体地,试剂和试剂是寡糖的衍生物,更具体地是β-葡聚糖。